BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24435653)

  • 1. In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes.
    Sivanathan L; Chow A; Wong A; Hoang VC; Emmenegger U
    Prostate; 2014 May; 74(5):537-46. PubMed ID: 24435653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
    Gao AC; Lou W; Isaacs JT
    Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer.
    Glinsky GV; Krones-Herzig A; Glinskii AB; Gebauer G
    Mol Carcinog; 2003 Aug; 37(4):209-21. PubMed ID: 12891630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of human prostate tumorigenic growth by azatyrosine.
    Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
    Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.
    Ragnum HB; Røe K; Holm R; Vlatkovic L; Nesland JM; Aarnes EK; Ree AH; Flatmark K; Seierstad T; Lilleby W; Lyng H
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):753-60. PubMed ID: 24035332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
    Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
    J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
    Vijayakumar S; Garcia D; Hensel CH; Banerjee M; Bracht T; Xiang R; Kagan J; Naylor SL
    Genes Chromosomes Cancer; 2005 Dec; 44(4):365-72. PubMed ID: 16080199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
    Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expressional changes in prostate fibroblasts from cancerous tissue.
    Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
    APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
    Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
    Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT; Blok LJ; Steenbeek M; Veldscholte J; van Weerden WM; van Steenbrugge GJ; Brinkmann AO
    Cancer Res; 1997 Sep; 57(18):4075-81. PubMed ID: 9307296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
    Chen MW; Vacherot F; De La Taille A; Gil-Diez-De-Medina S; Shen R; Friedman RA; Burchardt M; Chopin DK; Buttyan R
    Oncogene; 2002 Nov; 21(51):7861-71. PubMed ID: 12420223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.
    Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S
    J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.